Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma.

Autor: D'Agostino M; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy., Bertuglia G; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy., Rota-Scalabrini D; Medical Oncology Department Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-Istituto di Ricovero e Cura a Carattere Scientifico, Turin, Italy., Belotti A; Department of Hematology, Azienda Socio Sanitaria Territoriale Spedali Civili di Brescia, Brescia, Italy., Morè S; Clinica di Ematologia Azienda Ospedaliero Universitaria delle Marche, Università Politecnica delle Marche, Ancona, Italy., Corradini P; University of Milan, Milan, Italy; and Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Oliva S; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy., Ledda A; Ematologia/Centro Trapianti Midollo Osseo, Ospedale A. Businco, Cagliari, Italy., Grasso M; Azienda Ospedaliera S. Croce-Carle, Cuneo, Italy., Pavone V; Hematology and Bone Marrow Transplant, Hospital Cardinale G. Panico, Tricase, Italy., Ronconi S; IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Meldola, Italy., Vincelli ID; Divisione di Ematologia, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy., Ballanti S; Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, località Sant'Andrea delle Fratte, Perugia, Italy., Velluti C; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Cellini C; U.O.C. Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy., Gozzetti A; Department of Medicine, Surgery and Neurosciences, University of Siena, Policlinico S. Maria alle Scotte, Siena, Italy., Palmas AD; Struttura Complessa Ematologia, Ospedale San Francesco, Azienda Sanitaria Locale Nuoro, Nuoro, Italy., Gamberi B; Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Mancuso K; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Paris L; Division of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy., Zambello R; Hematology Section, Department of Medicine, Padua University School of Medicine, Padua, Italy., Petrucci MT; Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy., Bruno B; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy., Musto P; Department of Precision and Regenerative Medicine and Ionian Area, Aldo Moro University School of Medicine, Bari, Italy.; Hematology and Stem Cell Transplantation Unit, Azienda Ospedaliero-Universitaria Consorziale Policlinico, Bari, Italy., Gay F; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy.; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, University of Torino, Turin, Italy.

Publikováno v: Blood [Blood] 2024 Feb 15; Vol. 143 (7), pp. 592-596.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prognostic role of aspartate aminotransferase-lymphocyte ratio index in patients with metastatic colorectal cancer: results from the randomized ITACa trial

Autor: Casadei Gardini A, Scarpi E, Orlandi E, Tassinari D, Leo S, Bernardini I, Gelsomino F, Tamberi S, Ruscelli S, Vespignani R, Ronconi S, Frassineti GL, Amadori D, Passardi A

Publikováno v: OncoTargets and Therapy, Vol Volume 11, Pp 5261-5268 (2018)

Andrea Casadei Gardini,1,* Emanuela Scarpi,2,* Elena Orlandi,3 Davide Tassinari,4 Silvana Leo,5 Ilaria Bernardini,6 Fabio Gelsomino,7 Stefano Tamberi,8 Silvia Ruscelli,1 Roberto Vespignani,9 Sonia Ronconi,10 Giovanni Luca Frassineti,1 Dino Amadori,1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::59cb62d3ed498a6626b07da55a759bc7
https://www.dovepress.com/prognostic-role-of-aspartate-aminotransferase-lymphocyte-ratio-index-i-peer-reviewed-article-OTT

Carfilzomib induction, consolidation, and maintenance with or without autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma: pre-planned cytogenetic subgroup analysis of the randomised, phase 2 FORTE trial.

Autor: Mina R; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy., Musto P; Department of Precision and Regenerative Medicine and Ionian Area, 'Aldo Moro' University School of Medicine, Bari, Italy; Hematology and Stem Cell Transplantation Unit, AOU Consorziale Policlinico, Bari, Italy., Rota-Scalabrini D; Multidisciplinary Oncology Outpatient Clinic, Candiolo Cancer Institute, FPO - IRCCS, Turin, Italy., Paris L; Division of Hematology, ASST Papa Giovanni XXIII, Bergamo, Italy., Gamberi B; Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia, Italy., Palmas A; SC Ematologia, Ospedale San Francesco, Nuoro, Italy., Aquino S; Ematologia, Ospedale Policlinico San Martino, Genova, Italy., de Fabritiis P; Haematology, St Eugenio Hospital, Tor Vergata University, Rome, Italy., Giuliani N; University of Parma and University Hospital of Parma, Parma, Italy., De Rosa L; Hematology and SCT Unit, St Camillo Hospital, Rome, Italy., Gozzetti A; Department of Medicine, Surgery and Neurosciences, University of Siena, Policlinico S Maria alle Scotte, Siena, Italy., Cellini C; AUSL Romagna, UOC Ematologia, Ospedale Santa Maria delle Croci, Ravenna, Italy., Bertamini L; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy., Capra A; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Oddolo D; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Vincelli ID; Hematology Unit, Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Reggio Calabria, Italy., Ronconi S; IRCCS Istituto Romagnolo per lo Studio dei Tumori 'Dino Amadori'-IRST, Meldola, Italy., Pavone V; Department of Hematology and Bone Marrow Transplant, Hospital Cardinale G Panico, Tricase, Italy., Pescosta N; Reparto Ematologia, Ospedale Provinciale Bolzano, Bolzano, Italy., Cea M; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, and IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Fioritoni F; Ospedale Santo Spirito, Pescara, Italy., Ballanti S; Sezione di Ematologia e Immunologia Clinica, Ospedale Santa Maria della Misericordia, località Sant'Andrea delle Fratte, Perugia, Italy., Grasso M; Azienda Ospedaliera S Croce-Carle, Cuneo, Italy., Zamagni E; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy; Italy Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy., Belotti A; UO Ematologia, ASST Spedali Civili di Brescia, Brescia, Italy., Boccadoro M; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy., Gay F; Division of Hematology, Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy; Division of Hematology, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy. Electronic address: francesca.gay@unito.it.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2023 Jan; Vol. 24 (1), pp. 64-76. Date of Electronic Publication: 2022 Dec 14.

Patients with multiple myeloma referred for palliative care consultation: from retrospective analysis to future directions to improve clinical outcomes.

Autor: Pallotti MC; Palliative Care Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST), Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, FC, Italy. mcaterina.pallotti@irst.emr.it., Rossi R; Palliative Care Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST), Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, FC, Italy., Scarpi E; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, FC, Italy., Dall'Agata M; Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, FC, Italy., Ricci M; Palliative Care Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST), Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, FC, Italy., Ceccolini M; Hematology Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, FC, Italy., Ronconi S; Hematology Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, FC, Italy., Valenti V; Palliative Care Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST), Dino Amadori', Via P. Maroncelli 40, 47014, Meldola, FC, Italy., Maltoni M; Medical Oncology Unit, IRCCS Azienda Ospedaliero-Universitaria Bologna, Bologna, Italy.; Department of Specialized, Experimental and Diagnostic Medicine, University of Bologna, Bologna, Italy., Martinelli G; Scientific Directorate, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, FC, Italy., Cerchione C; Hematology Unit, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, FC, Italy.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Mar; Vol. 30 (3), pp. 2293-2298. Date of Electronic Publication: 2021 Oct 31.